NO20050127D0 - 9-alfa-substituerte ostratriener som selektivt aktive ostrogener - Google Patents

9-alfa-substituerte ostratriener som selektivt aktive ostrogener

Info

Publication number
NO20050127D0
NO20050127D0 NO20050127A NO20050127A NO20050127D0 NO 20050127 D0 NO20050127 D0 NO 20050127D0 NO 20050127 A NO20050127 A NO 20050127A NO 20050127 A NO20050127 A NO 20050127A NO 20050127 D0 NO20050127 D0 NO 20050127D0
Authority
NO
Norway
Prior art keywords
ostratrienes
oestrogens
alpha
substituted
selectively active
Prior art date
Application number
NO20050127A
Other languages
English (en)
Other versions
NO20050127L (no
NO329563B1 (no
Inventor
Karl-Heinrich Fritzemeier
Peter Muhn
Gerd Mueller
Dirk Kosemund
Alexander Hillisch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20050127D0 publication Critical patent/NO20050127D0/no
Publication of NO20050127L publication Critical patent/NO20050127L/no
Publication of NO329563B1 publication Critical patent/NO329563B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0055—Estrane derivatives not substituted in position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20050127A 2002-06-11 2005-01-10 9-alfa-substituerte ostratriener som selektivt aktive ostrogener, farmasoytiske preparater som inneholder forbindelsene, samt anvendelse derav til fremstilling av farmasoytiske midler NO329563B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10226326A DE10226326A1 (de) 2002-06-11 2002-06-11 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene
PCT/EP2003/006172 WO2003104253A2 (de) 2002-06-11 2003-06-11 9-alpha-substituierte estratriene als selektiv wirksame estrogene

Publications (3)

Publication Number Publication Date
NO20050127D0 true NO20050127D0 (no) 2005-01-10
NO20050127L NO20050127L (no) 2005-03-11
NO329563B1 NO329563B1 (no) 2010-11-15

Family

ID=29723144

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050127A NO329563B1 (no) 2002-06-11 2005-01-10 9-alfa-substituerte ostratriener som selektivt aktive ostrogener, farmasoytiske preparater som inneholder forbindelsene, samt anvendelse derav til fremstilling av farmasoytiske midler

Country Status (29)

Country Link
EP (1) EP1517914B1 (no)
JP (1) JP4615998B2 (no)
KR (1) KR101006612B1 (no)
CN (1) CN1293090C (no)
AR (1) AR040188A1 (no)
AT (1) ATE303397T1 (no)
AU (1) AU2003242683B9 (no)
BR (1) BR0312140A (no)
CA (1) CA2486495C (no)
CR (1) CR10289A (no)
CU (1) CU23414B7 (no)
DE (2) DE10226326A1 (no)
DK (1) DK1517914T3 (no)
EA (1) EA008442B1 (no)
EC (1) ECSP055530A (no)
ES (1) ES2248770T3 (no)
HK (1) HK1081203A1 (no)
HR (1) HRP20050009B1 (no)
IL (1) IL165321A (no)
MX (1) MXPA04012491A (no)
NO (1) NO329563B1 (no)
PE (1) PE20040613A1 (no)
PL (1) PL209910B1 (no)
RS (1) RS50878B (no)
TW (1) TWI286140B (no)
UA (1) UA78062C2 (no)
UY (1) UY27844A1 (no)
WO (1) WO2003104253A2 (no)
ZA (1) ZA200500217B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PT1689410E (pt) * 2003-11-26 2008-08-18 Bayer Schering Pharma Ag Prevenção e tratamento de doenças cardíacas hipertensivas pelos estrogénios selectivos 8beta-vinil-estra-1,3,5(10)-trieno-3,17beta-diol e 17beta-fluoro-9alfa-vinil-estra-1,3,5(10)-trieno-3,16alfa-diol
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
KR20100117603A (ko) * 2008-02-13 2010-11-03 바이엘 쉐링 파마 악티엔게젤샤프트 안정화 효과를 갖는 약물 전달 시스템
EP2143432A1 (en) 2008-07-11 2010-01-13 Bayer Schering Pharma AG 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer
JP2012509286A (ja) * 2008-11-21 2012-04-19 バイエル ファーマ アクチエンゲゼルシャフト 薬物送達システム
EP3185881B1 (en) 2014-08-26 2022-03-09 Betanien Hospital Methods, agents and compositions for treatment of inflammatory conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336432A1 (de) 1973-07-13 1975-01-30 Schering Ag 3.17.18-trihydroxy-1.3.5(10)-oestratriene
US6154158A (en) * 1998-06-30 2000-11-28 Qualcomm Incorporated Digital-to-analog converter D.C. offset correction comparing converter input and output signals
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
AU1855201A (en) * 1999-11-02 2001-05-14 Schering Aktiengesellschaft 18-nor-steroids as selectively active estrogens
JP3828423B2 (ja) * 2000-04-12 2006-10-04 シエーリング アクチエンゲゼルシャフト ８β−置換された１１β−ペンチル−及び１１β−ヘキシル−エストラ−１，３，５（１０）−トリエン誘導体類

Also Published As

Publication number Publication date
TW200407331A (en) 2004-05-16
CA2486495A1 (en) 2003-12-18
DE50301116D1 (de) 2005-10-06
HRP20050009B1 (hr) 2013-07-31
NO20050127L (no) 2005-03-11
KR20050009745A (ko) 2005-01-25
AR040188A1 (es) 2005-03-16
RS50878B (sr) 2010-08-31
WO2003104253A2 (de) 2003-12-18
ECSP055530A (es) 2005-03-10
IL165321A (en) 2009-08-03
AU2003242683B9 (en) 2009-08-27
HRP20050009A2 (en) 2005-04-30
EP1517914A2 (de) 2005-03-30
UA78062C2 (en) 2007-02-15
KR101006612B1 (ko) 2011-01-10
ES2248770T3 (es) 2006-03-16
NO329563B1 (no) 2010-11-15
EA008442B1 (ru) 2007-06-29
TWI286140B (en) 2007-09-01
BR0312140A (pt) 2005-04-05
UY27844A1 (es) 2003-12-31
PL373090A1 (en) 2005-08-08
CU23414B7 (es) 2009-09-08
CR10289A (es) 2008-11-26
AU2003242683A1 (en) 2003-12-22
EA200401544A1 (ru) 2005-06-30
PE20040613A1 (es) 2004-12-01
WO2003104253A3 (de) 2004-09-16
DE10226326A1 (de) 2004-01-15
AU2003242683B2 (en) 2009-07-02
CN1659181A (zh) 2005-08-24
CA2486495C (en) 2011-04-19
ZA200500217B (en) 2006-03-29
HK1081203A1 (en) 2006-05-12
EP1517914B1 (de) 2005-08-31
CN1293090C (zh) 2007-01-03
DK1517914T3 (da) 2006-01-16
JP2005533053A (ja) 2005-11-04
JP4615998B2 (ja) 2011-01-19
PL209910B1 (pl) 2011-11-30
MXPA04012491A (es) 2005-06-08
RS107004A (en) 2006-10-27
ATE303397T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
DK3473251T3 (da) Nikotin-cellulose-kombination
ATE457980T1 (de) Aryloxime
ATE534648T1 (de) C-6-modifizierte indazolylpyrrolotriazine
ATE318817T1 (de) Aza-arylpiperazine
ATE427876T1 (de) Luftkissenboot
DE50212349D1 (de) Hirurgie
DE50212360D1 (de) Anfahrhilfesteuerungsvorrichtung
DE50301200D1 (de) Wischblatt
ATE349458T1 (de) Etonogestrelester
NO20050127L (no) 9-alfa-substituerte ostratriener som selektivt aktive ostrogener
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
ATA1572002A (de) Managementspleisskassette
DE50301960D1 (de) Hydrolager
DE50301464D1 (de) Schraubensicherung
DE50302660D1 (de) Stopfmachine
NO20043664L (no) Ny fremgangsmate
ATA4142004A (de) Trägerverbau
ATE469773T1 (de) Zugöse
DE50303317D1 (de) Einschub-leistungsschalter
ATA19152002A (de) Hubkupplung
ITMI20021327A1 (it) Nuove ossialchilpiperazine
ATE396192T1 (de) N-sulfonylaminothiazole
FR2840006B1 (fr) Construction demontable
DE50300322D1 (de) Zylinderkopfdichtung
DE50303658D1 (de) Postgutmessvorrichtung

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MM1K Lapsed by not paying the annual fees